Intrathecal levels of vitamin D and IgG in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 125, Issue 6, 2012, Pages

  Holmoy T ^a   Lossius, A ^b   Gundersen, T E ^c   Moen, S M ^d   Castellazzi, M ^e   Fainardi, E ^e,f   Casetta, I ^e  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Vitas as   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF FERRARA   (Italy)

^f UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Cerebrospinal fluid; Immunoglobulin G; Immunology; Multiple sclerosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; IMMUNOGLOBULIN G;

CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NOTE; SYNTHESIS;

FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MULTIPLE SCLEROSIS; VITAMIN D;

EID: 84860120851     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01577.x     Document Type: Note

References (17)

1. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008;14:1220-4.
2. Simpson S Jr, Taylor B, Blizzard L et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010;68:193-203.
3. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009;132:1146-60.
4. Smolders J, Thewissen M, Peelen E, Terevaert E, Hupperts R, Demoiseaux J. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009;4:e6635.
5. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634-47.
6. Pincikova T, Nilsson K, Moen IE et al. Inverse relation between vitamin D and serum total immunoglobulin G in the scandinavian cystic fibrosis study. Eur J Clin Nutr 2011;65:102-9.
7. Vogt MH, Ten KJ, Drent RJ, Polman CH, Hupperts R. Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers. Mult Scler 2010;16:443-9.
8. Soilu-Hanninen M, Airas L, Mononen I, Heikkila A, Viljanen M, Hanninen A. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 2005;11:266-71.
9. De Abreu DA, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009;34(Suppl 1):265-77.
10. Spach KM, Hayes CE. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005;175:4119-26.
11. Holmoy T, Moen SM, Gundersen T et al. 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler 2009;15:1280-5.
12. Lefvert AK, Link H. IgG production within the central nervous system: a critical review of proposed formulae. Ann Neurol 1985;17:13-20.
13. Tibbling G, Link H, Ohman S. Principles of albumin and IgG analyses in neurological disorders: I. Establishment of reference value. Scand J Clin Lab Invest 1977;37:385-90.
14. Olsson T. Cerebrospinal fluid. Ann Neurol 1994;36(Suppl):S100-2.
15. Castellazzi M, Tamborino C, Cani A et al. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis. Mult Scler 2010;16:883-7.
16. Owens GP, Bennett JL, Lassmann H et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 2009;65:639-49.
17. Cantorna MT, Woodward WD, Hayes CE, Deluca HF. 1, 25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol 2009;160:5314-9.